,outcome,arm 1,arm 2
0,intervention,induction,
0,"leukopenia (, cytomegalovirus ( CMV ), incidence of adverse events, fever, herpes simplex","11.3 %, 32.5 %, 37.3 %",19.0 %
0,"incidence of adverse events, fever, cytomegalovirus ( CMV ), herpes simplex","17.9 %, 25.2 %",10.1 %
0,"leukopenia (, cytomegalovirus ( CMV ), incidence of adverse events, fever, herpes simplex, total study group","3.2 %, 5.7 %, 9.5 %","3.2 %, 5.7 %, 9.5 %"
0,"incidence of adverse events, total study group",thrombocytopenia (,thrombocytopenia (
